Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6C hi and Ly6C lo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice (Q58149069)
article by Christophe Combadière et al published April 2008 in Circulation
Language:
Current Data About Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6C hi and Ly6C lo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice
(P31) (Q13442814)

(P50) (Q40062632)
(P1932) Mathieu Rodero
(P1545) 3

(Q45827826)
(P1932) Ziad Mallat
(P1545) 10

(Q56457827)
(P1932) Tabassome Simon
(P1545) 4

(Q57298641)
(P1545) 9
(P1932) Alain Tedgui

(P304) 1649-1657

(P407) (Q1860)

(P433) 13

(P478) 117

(P577) +2008-04-00T00:00:00Z

(P921) (Q762713)

(Q12252367)
(P887)

(P1433) (Q578091)

(P1476) "Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6C hi and Ly6C lo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice" (language: en)

(P2093) Christophe Combadière
(P1545) 1

Stéphane Potteaux
(P1545) 2

Adeline Pezard
(P1545) 5

Bruno Esposito
(P1545) 6

Régine Merval
(P1545) 7

Amanda Proudfoot
(P1545) 8

other details
description article by Christophe Combadière et al published April 2008 in Circulation

External Links
(P356) 10.1161/CIRCULATIONAHA.107.745091
(P698) 18347211